Literature DB >> 23782086

Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders.

Bari J Ballew1, Sharon A Savage.   

Abstract

Dyskeratosis congenita (DC) is a cancer-prone inherited bone marrow failure syndrome caused by aberrant telomere biology. The mucocutaneous triad of nail dysplasia, abnormal skin pigmentation and oral leukoplakia is diagnostic, but is not always present; DC can also be diagnosed by the presence of very short leukocyte telomeres. Patients with DC are at high risk of bone marrow failure, pulmonary fibrosis, liver disease, cancer and other medical problems. Germline mutations in one of nine genes associated with telomere maintenance are present in approximately 60% of patients. DC is one among the group of clinically and biologically related telomere biology disorders, including Hoyeraal-Hreidarsson syndrome, Revesz syndrome, Coats plus (also known as cranioretinal microangiopathy with calcifications and cysts) and subsets of aplastic anemia, pulmonary fibrosis, nonalcoholic and noninfectious liver disease and leukemia. The authors review the pathobiology that connects DC and the related telomere biology disorders, methods of diagnosis and management modalities.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23782086     DOI: 10.1586/ehm.13.23

Source DB:  PubMed          Journal:  Expert Rev Hematol        ISSN: 1747-4094            Impact factor:   2.929


  53 in total

Review 1.  Neonatal manifestations of inherited bone marrow failure syndromes.

Authors:  Payal P Khincha; Sharon A Savage
Journal:  Semin Fetal Neonatal Med       Date:  2015-12-24       Impact factor: 3.926

Review 2.  An integrative review of factors associated with telomere length and implications for biobehavioral research.

Authors:  Angela R Starkweather; Areej A Alhaeeri; Alison Montpetit; Jenni Brumelle; Kristin Filler; Marty Montpetit; Lathika Mohanraj; Debra E Lyon; Colleen K Jackson-Cook
Journal:  Nurs Res       Date:  2014 Jan-Feb       Impact factor: 2.381

3.  Similar telomere attrition rates in androgen-treated and untreated patients with dyskeratosis congenita.

Authors:  Payal P Khincha; Alison A Bertuch; Shahinaz M Gadalla; Neelam Giri; Blanche P Alter; Sharon A Savage
Journal:  Blood Adv       Date:  2018-06-12

4.  Shorter Remission Telomere Length Predicts Delayed Neutrophil Recovery After Acute Myeloid Leukemia Therapy: A Report From the Children's Oncology Group.

Authors:  Robert B Gerbing; Todd A Alonzo; Lillian Sung; Alan S Gamis; Soheil Meshinchi; Sharon E Plon; Alison A Bertuch; Maria M Gramatges
Journal:  J Clin Oncol       Date:  2016-11-01       Impact factor: 44.544

Review 5.  Periodontal and other oral manifestations of immunodeficiency diseases.

Authors:  M E Peacock; R M Arce; C W Cutler
Journal:  Oral Dis       Date:  2016-10-10       Impact factor: 3.511

6.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report.

Authors:  Lindsay M Morton; Wael Saber; K Scott Baker; A John Barrett; Smita Bhatia; Eric A Engels; Shahinaz M Gadalla; David E Kleiner; Steven Pavletic; Linda J Burns
Journal:  Biol Blood Marrow Transplant       Date:  2016-09-12       Impact factor: 5.742

Review 7.  Genetic predisposition syndromes: when should they be considered in the work-up of MDS?

Authors:  Daria V Babushok; Monica Bessler
Journal:  Best Pract Res Clin Haematol       Date:  2014-11-12       Impact factor: 3.020

8.  Response to androgen therapy in patients with dyskeratosis congenita.

Authors:  Payal P Khincha; Ingrid M Wentzensen; Neelam Giri; Blanche P Alter; Sharon A Savage
Journal:  Br J Haematol       Date:  2014-02-12       Impact factor: 6.998

9.  Investigation of chromosome X inactivation and clinical phenotypes in female carriers of DKC1 mutations.

Authors:  Jialin Xu; Payal P Khincha; Neelam Giri; Blanche P Alter; Sharon A Savage; Judy M Y Wong
Journal:  Am J Hematol       Date:  2016-11-04       Impact factor: 10.047

Review 10.  Familial myelodysplastic syndrome/acute leukemia syndromes: a review and utility for translational investigations.

Authors:  Allison H West; Lucy A Godley; Jane E Churpek
Journal:  Ann N Y Acad Sci       Date:  2014-01-27       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.